Recent Updates
Recently added Catalysts

glycopyrronium Wipes

Phase 3

Hyperhidrosis | Small molecule | Other |Journey Medical Corporation|Last Updated: Aug 25, 2021

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLEDBiomarker
Total Trials3
Total Enrollment1,261
FDA Designations
No designations recorded
Clinical Trials (3)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02530294Study of Glycopyrronium in Subjects With Axillary HyperhidrosisPHASE3 COMPLETED 353Aug 1, 2015Apr 1, 2016Aug 25, 202120 United States
NCT02553798Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary HyperhidrosisPHASE3 COMPLETED 564Aug 1, 2015Dec 1, 2016Aug 25, 202148 United States, Germany
NCT02530281Study of Glycopyrronium in Axillary HyperhydrosisPHASE3 COMPLETED 344Jul 1, 2015Mar 1, 2016Aug 25, 202131 United States, Germany
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Percentage of Subjects Who Have a ≥4-point Improvement in the Weekly Mean Score of Axillary Sweating Daily Diary (ASDD) Item #2 From Baseline at Week 4
From Baseline to Week 4

The Axillary Sweating Daily Diary (ASDD) is a 4-item instrument designed to measure the severity of axillary hyperhidrosis and its impact on daily activities. The 4 Items are: 1. During the past 24 hours, did you have any underarm sweating? (Yes or No) 2. During the past 24 hours, how would you rate your underarm sweating at its worst? (0=No sweating at all, 1, 2,…, 10=Worst possible sweating) 3. During the past 24 hours, to what extent did your underarm sweating impact your activities? (0=Not at all, 1=A little bit, 2=A moderate amount, 3=A great deal and 4=An extreme amount) 4. During the past 24 hours, how bothered were you by your underarm sweating? (0=Not at all bothered, 1=A little bothered, 2=Moderately bothered, 3=Very bothered, 4=Extremely bothered)

Mean Absolute Change From Baseline in Gravimetrically-measured Sweat Production at Week 4
Baseline - Week 4

Subjects are acclimated to the environment for 30 minutes. Dry gauze is weighed. The dry gauze is then applied to the subject's axilla with the arm down by the subject's side or on their lap during the 5-minute period of sweat production. The gauze with the sweat is then weighed. The difference between the Weight of the gauze with sweat and the dry gauze is the gravimetric sweat measurement in mg/5min.

Median Absolute Change From Baseline in Gravimetrically-measured Sweat Production at Week 4
From Baseline to Week 4
Long-term Safety Assessed Through Adverse Events and Local Skin Reactions
Day 1 - Week 44

The Total Participants at risk are based on the Safety population, defined as, Participants who were randomized and received at least one confirmed dose of study drug.

Percentage of Subjects Who Have a ≥4-point Improvement in the Weekly Mean Score of ASDD Item #2 From Baseline at Week 4
From Baseline to Week 4

The Axillary Sweating Daily Diary (ASDD) is a 4-item instrument designed to measure the severity of axillary hyperhidrosis and its impact on daily activities. The 4 Items are: 1. During the past 24 hours, did you have any underarm sweating? (Yes or No) 2. During the past 24 hours, how would you rate your underarm sweating at its worst? (0=No sweating at all, 1, 2,…, 10=Worst possible sweating) 3. During the past 24 hours, to what extent did your underarm sweating impact your activities? (0=Not at all, 1=A little bit, 2=A moderate amount, 3=A great deal and 4=An extreme amount) 4. During the past 24 hours, how bothered were you by your underarm sweating? (0=Not at all bothered, 1=A little bothered, 2=Moderately bothered, 3=Very bothered, 4=Extremely bothered)

Mean Absolute Change From Baseline in Gravimetrically-measured Sweat Production at Week 4, Excluding Centers With Outlier Data
Baseline - Week 4
Secondary Endpoints
Percentage of Subjects Who Have a ≥2 Grade Improvement in Hyperhidrosis Disease Severity Scale (HDSS) From Baseline at Week 4
From Baseline to Week 4
Percentage of Subjects Who Have at Least a 50% Reduction in Gravimetrically Measured Sweat Production From Baseline at Week 4
From Baseline to Week 4
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingQUADRUPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
glycopyrroniumEXPERIMENTALglycopyrronium Topical Wipes
VehiclePLACEBO_COMPARATORglycopyrronium Topical Wipes, Vehicle
Interventions
NameTypeDescription
glycopyrronium Topical WipesDRUGTopical wipes containing glycopyrronium
VehicleOTHERVehicle (placebo) topical wipes
Unlock Study Design Details
Eligibility Criteria
Age Range9 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites20

Inclusion Criteria: * Male or female ≥ 9 years of age. * Primary, axillary hyperhidrosis of at least 6 months duration. * Hyperhidrosis Disease Severity Scale (HDSS) of 3 or 4 at Baseline. * Axillary Sweating Daily Diary (ASDD) ≥ 4 at Baseline. * Sweat production of at least 50 mg over 5 minutes in...

Countries:United StatesGermany
Unlock Eligibility Criteria